Search results
p16LUC model. Scientific career. Fields. Molecular genetics. Institutions. University of North Carolina at Chapel Hill. National Cancer Institute. Norman Edward "Ned" Sharpless (born September 20, 1966) is the previous Director of the National Cancer Institute (NCI).
Dec 7, 2021 · First person profile: Norman E. “Ned” Sharpless, MD. As director of the National Cancer Institute, Dr. Sharpless has turned a passion for research into a lifelong career. Ashley Hay BSN, RN. First published: 07 December 2021. https://doi.org/10.1002/cncr.34037.
- Ashley Hay BSN, RN
- 127, Issue24
- 07 December 2021
Apr 4, 2022 · Norman “Ned” Sharpless, director of the $6.9 billion National Cancer Institute (NCI) since late 2017, announced today that he will step down at the end of this month after nearly 5 years on the job. Sharpless’s announcement stunned many in the cancer research community.
Norman E. Sharpless, M.D. (he/him) Director, National Cancer Institute. r. E. “Ned” Sharpless was officially sworn in as the as of of the Lineberger appointment, of North Comprehensive. Institute (NCI) on Dr. Sharpless Center at the University he held since 2014. Sharpless his undergraduate a Morehead mathematics.
Senescence in health and disease. S He, NE Sharpless. Cell 169 (6), 1000-1011. , 2017. 1433. 2017. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16 INK4a. V Janzen, R Forkert, HE Fleming, Y Saito, MT Waring, DM Dombkowski, ...
Board Member, CEO Roundtable on Cancer, Co-CEO, Jupiter BioVentures, Professor of Cancer Policy and Innovation, University of North Carolina School of Medicine. Dr. Sharpless led the National Cancer Institute (NCI) from 2017 to 2022.
Apr 4, 2022 · Norman E. “Ned” Sharpless, M.D., announced today that he has decided to step down from his position as director of the National Cancer Institute (NCI), part of the National Institutes of Health, a position he has held since 2017.
